These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25738460)

  • 1. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice.
    Li P; Ruan X; Yang L; Kiesewetter K; Zhao Y; Luo H; Chen Y; Gucek M; Zhu J; Cao H
    Cell Metab; 2015 Mar; 21(3):455-67. PubMed ID: 25738460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway.
    Ma Y; Harris J; Li P; Cao H
    Mol Cell Endocrinol; 2021 Apr; 525():111191. PubMed ID: 33539963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c.
    Li D; Cheng M; Niu Y; Chi X; Liu X; Fan J; Fan H; Chang Y; Yang W
    Int J Biol Sci; 2017; 13(3):349-357. PubMed ID: 28367099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
    Bilz S; Samuel V; Morino K; Savage D; Choi CS; Shulman GI
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E716-22. PubMed ID: 16291572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
    Kast HR; Nguyen CM; Sinal CJ; Jones SA; Laffitte BA; Reue K; Gonzalez FJ; Willson TM; Edwards PA
    Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice.
    Chevre R; Trigueros-Motos L; Castaño D; Chua T; Corlianò M; Patankar JV; Sng L; Sim L; Juin TL; Carissimo G; Ng LFP; Yi CNJ; Eliathamby CC; Groen AK; Hayden MR; Singaraja RR
    FASEB J; 2018 Jul; 32(7):3792-3802. PubMed ID: 29481310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pectin penta-oligogalacturonide reduces cholesterol accumulation by promoting bile acid biosynthesis and excretion in high-cholesterol-fed mice.
    Zhu RG; Sun YD; Hou YT; Fan JG; Chen G; Li TP
    Chem Biol Interact; 2017 Jun; 272():153-159. PubMed ID: 28549616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates.
    Amano Y; Shimada M; Miura S; Adachi R; Tozawa R
    Eur J Pharmacol; 2014 Jan; 723():108-15. PubMed ID: 24361308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.
    Zhang Y; Liu C; Barbier O; Smalling R; Tsuchiya H; Lee S; Delker D; Zou A; Hagedorn CH; Wang L
    Sci Rep; 2016 Feb; 6():20559. PubMed ID: 26838806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
    Sinal CJ; Tohkin M; Miyata M; Ward JM; Lambert G; Gonzalez FJ
    Cell; 2000 Sep; 102(6):731-44. PubMed ID: 11030617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.
    Patankar JV; Wong CK; Morampudi V; Gibson WT; Vallance B; Ioannou GN; Hayden MR
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E418-E432. PubMed ID: 29066462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
    Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
    Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
    Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
    Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of triglyceride metabolism in patients with bile acid diarrhea.
    Sagar NM; McFarlane M; Nwokolo C; Bardhan KD; Arasaradnam RP
    World J Gastroenterol; 2016 Aug; 22(30):6757-63. PubMed ID: 27570415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
    Kawasaki M; Funabiki R; Yagasaki K
    Lipids; 1998 Sep; 33(9):905-11. PubMed ID: 9778138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNAs: Advances in Lipid Metabolism.
    Zeng Y; Ren K; Zhu X; Zheng Z; Yi G
    Adv Clin Chem; 2018; 87():1-36. PubMed ID: 30342708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.